MOBILE VIEW  | 

PAINT

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Liquid paints can be categorized as water-, solvent-, or oil- based. WATER-BASED paints typically contain latex or alkyd binders, pigments and extender pigments, biocides, plasticizers, drying agents, and surfactants, in a water base. Water-based paints include latex, tempera, and poster paints. SOLVENT-BASED paints contain relatively volatile organic solvents, such as xylene, toluene, light petroleum spirit, methyl ethyl ketone, ethanol, acetone, ethyl butyl acetate, or isopropanol. OIL-BASED paints use mineral oil as the solvent. The use of powder-based paints for industrial applications is increasing.

Specific Substances

    1) Paints
    2) Solvent-Base Paints
    3) Oil-Base Paints
    4) Alkyd Paints
    5) Latex Paints
    6) Water-Base Paints
    7) Paint (Corrosive)
    8) Paint Related Material (Corrosive)

Available Forms Sources

    A) FORMS
    1) LIQUID
    a) Liquid paints can be categorized as water-, solvent-, or oil- based.
    1) WATER-BASED paints typically contain latex or alkyd binders, pigments and extender pigments, biocides, plasticizers, drying agents, and surfactants, in a water base. Some of the ingredients are irritating to the skin and mucous membranes. They may also contain sensitizers, such as triethylamine, organic salts of cobalt and zirconium, and sodium dioctyl sulfosuccinate (Hansen et al, 1987). Detailed ingredients are given in Charretton (1987).
    a) Water-based paints include latex, tempera, and poster paints. Water-based paints are generally the least toxic of the major classes of paints. No serious health hazards are anticipated from their use (Hansen et al, 1987).
    2) SOLVENT-BASED paints contain relatively volatile organic solvents, such as xylene, toluene, light petroleum spirit, methyl ethyl ketone, ethanol, acetone, ethyl butyl acetate, or isopropanol. The solvent-based paints are often used in spray paint products because of their lower viscosity and faster drying properties. Their toxicity is due mainly to inhalation of the solvent vapors, particularly as a type of recreational substance abuse.
    3) OIL-BASED paints use mineral oil as the solvent. These dry more slowly and provide superior and more durable coverage than the water- or solvent-based paints. Their toxicity is mainly from the pigments.
    2) POWDER
    a) The use of powder-based paints for industrial applications is increasing. Powder-based paints require heat curing and do not contain any solvent. Formulations include polyester, acrylic, epoxy, epoxy-polyester hybrids, polytetraglycidal isocyanate (TGIC), and nylon (Reisch, 1990). Occupational exposures are usually from spraying applications.
    3) RADIATION CURED
    a) Paints which are cured by electron beam or ultraviolet radiation may contain aliphatic isocyanates and polyisocyanates as the active ingredients and polyols as stabilizers. They may also contain photoinitiators, optical brighteners, and light stabilizers (Reisch, 1991).
    b) Radiation-cured paints are used in industrial applications and contain acrylates of the following classes: mono-, di-, or trifunctional, epoxy, amine, urethane, or polyester. The acrylates used in radiation-cured coatings can cause skin and eye irritation and sensitization, and are possible skin carcinogens (Reisch, 1991).
    4) ADDITIVES
    a) In addition to the solvent and pigment, paints may contain a variety of additives including defoamers, deflocculants, biocides, (Reisch, 1990), surfactants, fillers, binders (alkyd resins, nitrocellulose), and catalysts.
    5) SOLVENTS
    a) Paints and lacquers contain a mixture of aromatic solvents (C9-C10) designated solveso 100 or shell soll A, xylene, light petroleum spirit, thinner (a mixture of light petroleum spirit, toluene, methyl ethylketone), ethanol, acetone, ethylbutyl acetate and isopropranol.
    b) Varnishes contain mainly xylene and toluene but also small amounts of other solvents such as ethanol, isopropranol, ethyl acetate, and N-butanol. Many types of paints, varnishes and printing ink contain a mixture of alcohols (ethanol, propranol, butanol, etc.) and aliphatic and aromatic organic solvents.
    6) LEAD
    a) Lead in paint is usually in the form of lead carbonate. It gains access to the body when paint chips are eaten, when paint is sucked, when the dust of the paint is picked up on the hands of toddlers, during house renovation, or when painted metal is cut with an acetylene torch.
    b) Since 1977, household paint must contain no more than 0.06% (600 ppm) lead by dry weight. Overt lead poisoning usually occurs in housing built before World War II. A chip of old or industrial paint the size of a thumbnail may contain 50 to 200 mg of lead. For comparison, the average dietary intake of lead in children is only 20 to 80 micrograms per day (Anon, 1987).
    c) HOME TEST KIT: A sodium sulfide-containing home lead paint test kit is available under the trade name Lead Detective, from Innovative Synthesis Corporation, 45 Lexington St, Ste 2, Newton, MA 02165.
    d) Lead-containing pigments that have been used in paints include (Joly et al, 1987):
    1) calcium plumbate
    2) ceruse (basic lead carbonate)
    3) chromium yellows
    4) lead cyanamide
    5) lead phosphite
    6) metallic lead
    7) minium
    8) molybdenum reds
    e) The solubility of lead-based pigments in gastric fluid determines the hazard after ingestion. Pigments with partial solubility include lead minium, basic lead carbonate, and metallic lead. Other pigments that are practically insoluble in gastric fluid include lead chromate, lead silicochromate, lead sulfochromate, and lead sulfochromomolybdate (Joly et al, 1987).
    f) Alkyd paints may contain drying agents, such as lead naphthenate or lead octoate. Usual concentrations are 0.1 to 0.3% (Joly et al, 1987).
    g) Blood lead levels in children living in homes undergoing refinishing of lead paints were elevated an average of 69 percent (Rabinowitz et al, 1985).
    7) MERCURY
    a) Indoor latex paint may contain up to 300 ppm of mercury as a preservative (CDC, 1990).
    b) Exterior latex paints may contain mercury fungicides. "Mildew-Resistant" house paints usually have mercury compounds (phenylmercury oleate, phenylmercury acetate, or phenylmercury succinate). If there is less than 0.2% mercury compound, the special warning label is not required (Gosselin, 1984).
    c) The use of mercury-based biocides in INTERIOR paints was canceled by the US EPA, effective August 20, 1990. Existing stocks of pesticides were allowed to be sold and used for manufacture of exterior products until June 27, 1991, provided they are properly labeled with language prohibiting use in interior paints and coatings (EPA, 1990).
    d) Because current inventories were not affected, paints containing mercury-based biocides may still be available on the market.
    e) Median level of airborne mercury detected in homes recently painted with latex paint containing phenylmercuric acetate was 10.0 nmol/m(3), and urinary mercury levels of persons living in these houses were also elevated when compared with unexposed persons (4.7 nmol/mmol creatinine versus 1.1 nmol/mmol). Urinary concentrations were in the range associated with symptomatic mercury poisoning (Agocs et al, 1990).
    8) ORGANOTIN
    a) Marine paints often contain organotin polymers, usually tributyl tin oxide (TBTO), as antifouling agents to control growth of barnacles on hulls below the waterline (Reisch, 1990). TBTO is a strong irritant which can cause delayed pruritus, erythema, and vesiculation at the points of contact (Lewis & Emmett, 1987).
    b) Tributyl tin has also been used in interior house paint (Wax & Dockstader, 1995).
    9) AZO DYES
    a) Benzidine-derived azo dyes have been used in certain paints (Gregory, 1984). These have been speculated as a possible cause of increased risk of bladder cancer in painters (Myslak et al, 1991).
    10) ISOCYANATES
    a) Automobile paints may contain isocyanates, which can be potent sensitizers (Reisch, 1991).
    b) The airborne concentration of isocyanates during spraying operations can be high. In one study, levels of hexamethylene- diisocyanate monomer often exceeded 0.07 mg/m(3), the oligomer was at least ten-fold higher. Combined charcoal and particle filters on respirators were required to prevent significant exposure by the inhalation route (Rosenberg & Tuomi, 1984).
    11) AEROSOLS
    a) The distribution of the chemical components of a paint may vary with different sized aerosol fractions. Therefore, actual inhalation exposure may be different from the overall chemical composition of the paint (D'Arcy & Chan, 1990).
    B) USES
    1) Interior and exterior architectural coatings comprised more than half of all paint sold in the US in 1990. Product coatings, including automotive and appliance paints, accounted for 32% of volume. Special-purpose coatings were 16% (Reisch, 1991).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Paints are used on a wide variety of exterior and interior surfaces for decorative purposes and to protect from corrosion and environmental wear.
    B) TOXICOLOGY: Water based paints are primarily irritants. Solvent based paints contain relatively volatile organic solvents such as toluene, xylene, light petroleum spirit, methyl ethyl ketone, ethanol, acetone, ethyl butyl acetate, or isopropanol. Toxicity is primarily due to chronic inhalation as a consequence of recreational substance abuse; see specific solvent management for more information. Oil based paints use mineral oil as the solvent which can cause GI upset and diarrhea. Latex paint prior to 1950 may contain lead acetate, and prior to 1990 may contain phenylmercuric acetate. Oil based paints can contain lead, chromate, cadmium, arsenic, manganese, mercury, cobalt, and barium as pigments. See specific management for further details on these substances.
    C) EPIDEMIOLOGY: Exposures to children are common and rarely cause significant toxicity. Chronic occupational exposure can cause skin and mucous membrane irritation.
    D) WITH POISONING/EXPOSURE
    1) WATER BASED PAINTS: Include latex, tempera, and poster paints. These paints may be mildly irritating to skin and mucous membranes, but serious toxicity is not expected. Large doses (greater than 5 mL/kg) may cause nausea and vomiting without systemic toxicity. Some latex paints contain 5% to 10% glycols; potential glycol poisoning should be assessed in those patients who ingest large volumes.
    2) SOLVENT BASED PAINTS: Contain relatively volatile organic solvents such as toluene, xylene, light petroleum spirit, methyl ethyl ketone, ethanol, acetone, ethyl butyl acetate, or isopropanol. Toxicity is primarily due to chronic inhalation as a consequence of recreational substance abuse (inhalant abuse or solvent abuse) and includes encephalopathy and metabolic acidosis if the solvent is toluene due to its metabolite hippuric acid. Acute exposure may cause CNS depression and there is potential for aspiration after ingestion. However the risk for this is not great because of the small amounts typically ingested and because of the viscous nature of these products.
    3) OIL BASED PAINTS: Oil based paints use mineral oil as the solvent, which can cause GI upset and diarrhea. Risk is not great because of the small amounts typically ingested and because the viscous nature of these products makes aspiration unlikely. Lead, chromate, cadmium, arsenic, manganese, mercury, cobalt, and barium may be added as pigments. Toxicity is expected primarily with chronic exposure, but may result from acute ingestion of sufficient quantities.
    4) SPECIALTY PAINTS: Active ingredients of some specialty paints can be significant sources of toxicity. Isocyanate-based automobile paints are potent pulmonary sensitizers.
    0.2.20) REPRODUCTIVE
    A) Paternal occupation as a painter has been linked with increased risk of certain birth defects.
    0.2.21) CARCINOGENICITY
    A) Persons chronically exposed to paint may be at increased risk for bladder tumors, laryngeal or esophageal cancer, lung cancer, cancers of the bowel/rectum and intrahepatic bile ducts, and leukemia and multiple myeloma.

Laboratory Monitoring

    A) No specific lab work is needed after exposure to most paints.
    B) Obtain a serum lead concentration after acute ingestion or chronic exposure to lead based paint.
    C) Obtain urinary (mercury, manganese, cobalt), blood (cadmium, manganese) concentrations of specific heavy metals after significant exposure to paints that contain them.
    D) Obtain serum electrolytes after deliberate or prolonged inhalation of paint containing toluene or ingestion of paint containing barium.
    E) Obtain CBC, renal function, and hepatic enzymes in symptomatic patients.
    F) Chest radiographs as needed clinically for suspected aspiration.
    G) An abdominal radiograph may be useful to assess the adequacy of decontamination after ingestion of paint containing lead or other heavy metals.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Treatment is symptomatic and supportive.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Chelation may be necessary for patients with significant exposure to paints containing heavy metals. OBSERVE FOR ASPIRATION PNEUMONITIS and treat accordingly (see hydrocarbon management). Suspect aspiration if coughing or choking occurs following ingestion of oil-based paints. Aspiration pneumonitis should be treated with oxygen, inhaled beta agonists for bronchospasm, and in severe cases endotracheal intubation may be necessary.
    C) DECONTAMINATION
    1) PREHOSPITAL: GI decontamination is generally not indicated because of the low risk of acute toxicity and the possibility of aspiration. Activated charcoal can be considered after ingestion of lead based paint. Wash exposed skin with soap and water; mineral oil may help remove oil based paint. Irrigate exposed eyes.
    2) HOSPITAL: GI decontamination is generally not indicated because of the low risk of acute toxicity and the possibility of aspiration. Activated charcoal and/or gastric lavage can be considered after substantial ingestion of lead based paint. Wash exposed skin with soap and water; mineral oil may help remove oil based paint. Irrigate exposed eyes.
    D) CHELATION
    1) Consider early chelation in patients with significant ingestion of paints containing heavy metals or symptoms of acute heavy metal poisoning. See monograph pertaining to the specific heavy metal for details.
    E) ENHANCED ELIMINATION PROCEDURE
    1) Hemodialysis and hemoperfusion are not useful.
    F) PATIENT DISPOSITION
    1) HOME CRITERIA: Patients with symptoms limited to minor irritation after inadvertent exposure to paints that do not contain heavy metals can be managed at home.
    2) OBSERVATION CRITERIA: Patients with clinical evidence of aspiration (cough, increased work of breathing, wheezing) or ingestion of paints that contain heavy metals should be referred to a healthcare facility. Patients who deliberately inhale solvent based paint should be referred to a healthcare facility.
    3) ADMISSION CRITERIA: Patients with persistent symptoms of aspiration or with acute symptoms of heavy metal poisoning should be admitted.
    4) CONSULT CRITERIA: Consult a medical toxicologist or poison center for patients with significant ingestions of paints containing heavy metals. Refer patients who recreationally inhale solvent based paints for substance abuse counseling. Consult a pulmonologist for patients with severe aspiration.
    G) PITFALLS
    1) Acute exposure is generally minimally toxic, avoid over treating. Patients with exposure to lead based paints require ongoing follow up of blood lead concentrations.
    H) TOXICOKINETICS
    1) Unknown
    I) DIFFERENTIAL DIAGNOSIS
    1) Exposure to solvents, hydrocarbons.
    0.4.3) INHALATION EXPOSURE
    A) INHALATION: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with an inhaled beta2-adrenergic agonist. Consider systemic corticosteroids in patients with significant bronchospasm.
    0.4.4) EYE EXPOSURE
    A) Eye irritation may be noted after ocular exposure.
    B) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION: Wash affected area twice with soap and water. Oil-based paints may be removed from the skin with mineral oil (baby oil). A physician may need to examine the exposed area if irritation or pain persists.

Range Of Toxicity

    A) TOXICITY: A toxic dose is not known because of the variety and concentrations of ingredients in paints. A dose of concern is about 5 mL/kg.
    B) Symptomatic heavy metal toxicity (eg, arsenic, mercury) is unlikely following ingestion, unless massive amounts have been ingested or smaller amounts have been ingested or inhaled over a long period of time. Elevated blood lead concentrations can develop after acute ingestion of lead based paints.

Summary Of Exposure

    A) USES: Paints are used on a wide variety of exterior and interior surfaces for decorative purposes and to protect from corrosion and environmental wear.
    B) TOXICOLOGY: Water based paints are primarily irritants. Solvent based paints contain relatively volatile organic solvents such as toluene, xylene, light petroleum spirit, methyl ethyl ketone, ethanol, acetone, ethyl butyl acetate, or isopropanol. Toxicity is primarily due to chronic inhalation as a consequence of recreational substance abuse; see specific solvent management for more information. Oil based paints use mineral oil as the solvent which can cause GI upset and diarrhea. Latex paint prior to 1950 may contain lead acetate, and prior to 1990 may contain phenylmercuric acetate. Oil based paints can contain lead, chromate, cadmium, arsenic, manganese, mercury, cobalt, and barium as pigments. See specific management for further details on these substances.
    C) EPIDEMIOLOGY: Exposures to children are common and rarely cause significant toxicity. Chronic occupational exposure can cause skin and mucous membrane irritation.
    D) WITH POISONING/EXPOSURE
    1) WATER BASED PAINTS: Include latex, tempera, and poster paints. These paints may be mildly irritating to skin and mucous membranes, but serious toxicity is not expected. Large doses (greater than 5 mL/kg) may cause nausea and vomiting without systemic toxicity. Some latex paints contain 5% to 10% glycols; potential glycol poisoning should be assessed in those patients who ingest large volumes.
    2) SOLVENT BASED PAINTS: Contain relatively volatile organic solvents such as toluene, xylene, light petroleum spirit, methyl ethyl ketone, ethanol, acetone, ethyl butyl acetate, or isopropanol. Toxicity is primarily due to chronic inhalation as a consequence of recreational substance abuse (inhalant abuse or solvent abuse) and includes encephalopathy and metabolic acidosis if the solvent is toluene due to its metabolite hippuric acid. Acute exposure may cause CNS depression and there is potential for aspiration after ingestion. However the risk for this is not great because of the small amounts typically ingested and because of the viscous nature of these products.
    3) OIL BASED PAINTS: Oil based paints use mineral oil as the solvent, which can cause GI upset and diarrhea. Risk is not great because of the small amounts typically ingested and because the viscous nature of these products makes aspiration unlikely. Lead, chromate, cadmium, arsenic, manganese, mercury, cobalt, and barium may be added as pigments. Toxicity is expected primarily with chronic exposure, but may result from acute ingestion of sufficient quantities.
    4) SPECIALTY PAINTS: Active ingredients of some specialty paints can be significant sources of toxicity. Isocyanate-based automobile paints are potent pulmonary sensitizers.

Vital Signs

    3.3.2) RESPIRATIONS
    A) DYSPNEA was reported after use of hexamethylene and toluene diisocyanate-based spray paint (Nielsen et al, 1985).
    3.3.3) TEMPERATURE
    A) FEVER: Chills and fever have been reported following the use of hexamethylene and toluene diisocyanate-based spray paint (Nielsen et al, 1985).

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Eye irritation was one of the most commonly reported symptoms among users of water-based paints (Hansen et al, 1987; Wieslander et al, 1994). However, eye irritation is more pronounced after exposure to solvent based paint as compared to water based paint (Wieslander et al, 1994).
    a) Polyisocyanate paints were associated with conjunctivitis in 43% of subjects (Welinder et al, 1988).
    b) Watery, irritated eyes developed in 5 patients exposed to an interior paint containing tributyltin (Wax & Dockstader, 1995).
    2) KERATITIS: Superficial keratitis may develop after use of spray paints due to inadvertent impregnation of the cornea (MacLean, 1967).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) RHINITIS: Nose irritation has been reported after occupational exposure to reactive dyes (Hagmar et al, 1986).
    a) Nose irritation was one of the most commonly reported symptoms among users of water-based paints (Hansen et al, 1987).
    b) Rhinitis was reported in 43 percent of persons using polyisocyanate paints (Welinder et al, 1988).
    c) Painters exposed to epoxy paints had a higher incidence of nasal congestion than did non-exposed control subjects (Rempel et al, 1991).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) PULMONARY ASPIRATION
    1) Aspiration pneumonitis is a potential consequence of paint ingestion. Although paints contain hydrocarbons in large concentrations, the likelihood of aspiration is usually reduced because of the viscosity of the finished product.
    B) RESPIRATORY FAILURE
    1) Pulmonary function abnormalities consistent with air flow obstruction (decreased FEV1, vital capacity and peak expiratory flow) have been found in spray paint abusers (Reyers de la Roche, 1987), construction painters (Schwartz & Baker, 1988), automobile painters exposed to hexamethylenediisocyanate who also smoked (Tornling et al, 1990), automobile painters exposed to toluene diisocyanate (Parker et al, 1991), painters exposed to epoxy paints (Rempel et al, 1991), and painters exposed to water-born paints (Ulfvarson et al, 1992).
    C) IRRITATION SYMPTOM
    1) Repeated or prolonged exposure to high concentrations of dusts of reactive dyes (fiber reactive dyes derived from azo, anthraquinone, and phthalocyanine classes) (Procion(R)), has resulted in pulmonary allergic sensitization with cough, chest tightness, and/or asthmatic wheezing (Alanko et al, 1978; Hagmar et al, 1986; Estlander, 1988). This is believed to be an IgE mediated (type I) reaction (Hagman et al, 1986).
    2) A higher prevalence of respiratory symptoms was reported among automobile spray painters using isocyanate-based paints, than mechanics or industrial paint sprayers (Pisaniello & Muriale, 1989).
    3) Painters exposed to epoxy paints had a higher incidence of lower respiratory symptoms such as cough, wheezing, chest tightness and shortness of breath compared with non-exposed control subjects (Rempel et al, 1991). In a study of house painters, Wieslander et al (1997) found that painters exposed only to water based paints had fewer self-reported symptoms related to airway obstruction or bronchial hyperresponsiveness as compared to solvent based painters, but noted that airway irritation can still occur among selected individuals.
    D) REACTIVE AIRWAYS DYSFUNCTION SYNDROME
    1) Exposure to isocyanate-based acrylic paints may induce asthma in sensitive individuals (Selden et al, 1989). Pulmonary reactions to isocyanates in paints may be life-threatening (Belin et al, 1981).
    2) Five patients exposed to a tributyltin containing interior paint complained of wheezing; mild expiratory wheezing was present on physical exam in the two youngest children (ages 35 and 28 months) only (Wax & Dockstader, 1995).
    3) Two men developed fever and dyspnea with residual hyperreactive airways after electric arc welding steel painted with a chloro-containing polymer lacquer (Sjogren et al, 1991).
    4) CASE REPORT: A 39-year-old man developed cough, dyspnea, severe airway obstruction, hypoxia, fever and leukocytosis after working in a factory where boards were painted with a paint containing an epoxy resin and a carboxylated polyester (Cartier et al, 1994).
    a) The patient improved after treatment with inhaled beta agonists and oral steroids, but had persistent mild reactive airway disease. The reaction recurred after exposure to heated granular polyester.
    E) PNEUMONIA
    1) CASE SERIES: In 8 textile printing factories in Spain, an outbreak of severe interstitial lung disease occurred, in which 6 deaths from pneumonia were reported (Moya et al, 1994). The outbreak was considered to be secondary to a change in products (Acramin FWR was substituted for Acramin FWN).
    a) In a 12-month follow-up of 27 of the most highly exposed textile sprayers, 15 had persistent symptoms, 6 had radiological alterations, and diffusion capacity was reduced in nine individuals (Sole et al, 1996).
    2) CASE SERIES: Five female workers who spray painted lace cloth developed respiratory distress, cough, fever, cyanosis, obstructive airway disease, hypoxia and bilateral alveolar-interstitial infiltrates on chest x-ray (Kadi et al, 1994). One patient died, and two others were left with permanent pulmonary disease. The responsible agent was believed to be Acramin FWN, an agent banned from Spain after causing similar pulmonary toxicity.
    F) DEAD
    1) In one study, painters showed elevated risk of mortality from nonmalignant respiratory disease (Englund, 1980).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM FINDING
    1) Headache, lightheadedness, and fatigue are commonly reported after acute exposure to paint fumes (Hansen et al, 1987; Atkinson et al, 1989). Severe exposure in poorly ventilated areas may cause ataxia, amnesia, confusion and lethargy (Atkinson et al, 1989).
    B) TOXIC ENCEPHALOPATHY
    1) Chronic exposure to paints and solvents due to recreational substance abuse is associated with a toxic encephalopathy characterized by memory impairment, difficulty concentrating, fatigue, headache, dizziness, apathy, depression, anxiety, and personality changes.
    2) Decreased cerebral blood flow, cerebral atrophy, and vestibular dysfunction have been found in paint and solvent exposed workers with evidence of encephalopathy (Riusberg & Hegstadius, 1983; Orbaeck et al, 1985; Arlien-Soborg, 1984).
    3) Neurologic effects do not appear to reverse with cessation of exposure (Arlien-Soborg, 1984; Brhun et al, 1981).
    C) COLOR VISION DEFICIENCY
    1) Workers in a paint manufacturing plant who were highly exposed to organic solvents had an increased incidence of loss of blue-yellow color vision compared with moderately exposed workers (Mergler & Blain, 1987).
    D) HEADACHE
    1) Headache was one of the most commonly reported symptoms among users of water-based paints (Hansen et al, 1987).
    E) IMPAIRED COGNITION
    1) NEUROPSYCHOLOGIAL PERFORMANCE: Several studies have suggested that people with chronic occupational exposure to paint and solvents perform more poorly on tests of learning, memory, visual perception, and attention (Colvin et al, 1993; Spurgeon et al, 1992; Daniell et al, 1993; Chen et al, 1999).
    2) PAINTER'S SYNDROME - An irreversible deterioration of cognitive function, called painter's syndrome or ORGANIC SOLVENT DISEASE, has been described in painters after many years of exposure. Solvents are thought to be the causative agents; the possible additional effect of heavy metal pigments has not been explored. Structural changes on CT scans may be evident in the later stages. Psychiatric changes involve memory loss, personality change, depression, and anxiety (Linz et al, 1986).
    a) CASE SERIES: Neuropsychological effects were irreversible in a group of 26 painters two years after removal from exposure (Bruhn et al, 1981).
    b) CASE SERIES: Neuropsychiatric effects were NOT seen in a group of 187 male workers involved in the manufacture of paint, where exposure to solvents had been a minimum of 6 years (Bolla et al, 1990).
    c) A review of the literature on organic solvent disease has concluded that neuropsychiatric tests, EEG and CT scans are not suitable for group studies, and the psychiatric effects of chronic exposure to paint and/or solvents may be questionable (Grasso et al, 1984).
    d) Another review of the Danish literature has concluded that occupational exposure to paint solvents has not been proven to cause a presenile dementia (Errebo-Knudsen & Olsen, 1986).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) GASTRITIS
    1) Nausea and diarrhea may occur. Gamboge (from Garcinia hanburyi) is a cathartic and irritant.
    2) CASE SERIES: Five patients exposed to interior paint containing tributyltin developed nausea and vomiting (Wax & Dockstader, 1995).
    B) DEAD
    1) Painters showed elevated risk of mortality from nonmalignant disease of the upper gastrointestinal tract (Englund, 1980).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) CIRRHOSIS OF LIVER
    1) Stenosis, portal tract enlargement, and fibrosis which persisted for over a year has been reported in house painters following long-term occupational exposure to organic solvents (Dossing et al, 1983).
    B) LIVER ENZYMES ABNORMAL
    1) CHRONIC TOXICITY
    a) Elevated alanine aminotransferases to about three times above the upper limit of normal has been reported in patients following chronic exposure to aliphatic and aromatic organic solvents (Dossing et al, 1983).
    b) Increases in gamma-glutamyl transferase (GGT) were found in painters exposed to solvents (Chen et al, 1991). In spray painters, higher levels of GGT were reported among workers highly exposed to solvents versus workers with low levels of exposure (Liu et al, 1996).
    c) Evidence of liver cell damage was seen following heavy acute exposure to the fumes of a polyurethane-based paint (Atkinson et al, 1989).
    d) In a prospective-cohort study, spray painters exposed to solvent mixtures had higher levels of serum bile acids compared to non-exposed workers (Liu et al, 1996). However, other liver function studies were normal. The long-term effects of elevated serum bile were not known.

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) METHEMOGLOBINEMIA
    1) Ingestion of a paint containing toluidine red may result in methemoglobinemia (McCann, 1979).
    B) MYELOSUPPRESSION
    1) Transient bone marrow depression may be seen following heavy acute exposure to the fumes of polyurethane-based paint (Atkinson et al, 1989).
    C) HEMATOLOGY FINDING
    1) LEAD POISONING: Blood disorders characteristic of lead poisoning were seen in persons manufacturing paint under uncontrolled conditions (Tangredi et al, 1981).
    D) LEUKOCYTOSIS
    1) CASE REPORT (ADULT): Leukocytosis was seen in a spray painter following application of a hexamethylene and toluene diisocyanate-based paint (Nielsen et al, 1985).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) CONTACT DERMATITIS
    1) Allergic contact dermatitis is a common problem among workers exposed to paint, or in some case in individuals exposed to painted or lacquerware jewelry. Contact dermatitis has been associated with exposure to paints containing amino-substituted diacrylate, isothiazolinones, methyl ethyl ketone peroxide, triglycidyl isocyanurate, epoxy resins, lacquer, and other components.
    a) References: (Carmichael & Foulds, 1993; Sanz-Gallen et al, 1992; Greig, 1991; McFadden & Rycroft, 1993; Moura et al, 1994; Finkbeiner & Kleinhans, 1994; Fischer et al, 1995; Stewart & Beck, 1992) Munro & Lawerence, 1992; (Foulds & Koh, 1992; Omer & Al-Tawil, 1994; Kullavanijaya & Ophaswongse, 1997)
    2) Allergic contact dermatitis has been reported after the use of paints containing reactive dyes or triglycidyl isocyanurate (Estlander, 1988; Stern, 1985; Thoren et al, 1986; Mathias, 1988) Dooms-Goossens et al, 1989; (Foulds & Koh, 1992).
    3) DELAYED pruritus, erythema, and vesiculation on the wrists and forearms, has occurred after exposure to antifouling paints containing tributyl tin oxide (Goh, 1985; Lewis & Emmett, 1987).
    B) ACNE
    1) Irritant contact folliculitis was seen in a painter using a paint containing triphenyl tin fluoride (Andersen & Petri, 1982).
    C) CHEMICAL BURN
    1) CASE REPORT: Second degree burn over 70 percent of the body surface area developed in a 22-year-old man who lost consciousness while painting a bathroom with a toluene-based sealer. It was estimated that he had skin contact with the spilled sealer for approximately five hours prior to receiving dermal decontamination. Shortly after arrival the patient developed asystole and was successfully resuscitated. However, coagulation necrosis of the burned skin, rhabdomyolysis, non-oliguric renal failure, and anoxic brain injury occurred and the patient died on the sixth hospital day (Shibata et al, 1994).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) INJECTION SITE REACTION
    1) High-pressure injection injury of tissues is a hazard from the use of paint guns. Solvent-based paints injected into tissue can cause dissolution of fat and other tissues, resulting in necrosis of subcutaneous tissue and thrombosis of vessels, a 60 to 80 percent amputation rate, and possible systemic toxicity.
    2) The majority of cases involve the hands (Scott, 1983; Neal & Burke, 1991). Of 14 injuries, 3 required digital amputation (Mrvos et al, 1987).
    3) Paint solvents are most damaging because of their low viscosity and rapid spread through tissues (Schoo et al, 1980; Kaufman, 1968; Thacker et al, 1986; Herrick et al, 1980).
    4) Systemic effects can occur within the first 48 hours; effects may persist for 4 to 6 days (Harter & Harter, 1986).
    5) Factors which appear to correlate with worse prognosis include (Neal & Burke, 1991):
    a) Greater time from injury to decompression
    b) More irritant types of material injected
    c) Greater quantity of material injected
    d) Greater injection pressure of appliance
    e) Secondary infection
    f) More distal site of injection

Immunologic

    3.19.2) CLINICAL EFFECTS
    A) INCREASED IMMUNOGLOBULIN
    1) IgG ANTIBODIES: Titers for IgG antibodies against hexamethylene diisocyanate and its oligomers were detected in blood from automobile painters who had used polyisocyanate-containing paints (Welinder et al, 1988; (Selden et al, 1989).

Reproductive

    3.20.1) SUMMARY
    A) Paternal occupation as a painter has been linked with increased risk of certain birth defects.
    3.20.2) TERATOGENICITY
    A) HUMANS
    1) PATERNAL EXPOSURE: Paternal occupation as a painter was associated with increased odds ratios for spina bifida, patent ductus arteriosus, and cleft palate among 14,415 live births in British Columbia between 1952 and 1973 (Olshan et al, 1991).
    2) Solvent exposure has also been associated with birth defects and other reproductive disorders. In Finnish studies, the risk of CNS defects in the children of women working with solvents was increased (Holmberg, 1979; Holmberg & Nurminen, 1980). In a Danish study of female painters, there was an increased risk of spontaneous abortions that could not be attributed to a single chemical (Heidam, 1984).
    3) Paint sniffing is a major form of solvent abuse. Three of 5 children born to women who sniffed paint were growth-retarded, and 2 had craniofacial abnormalities and hyperchloremic acidosis (Goodwin, 1988).

Carcinogenicity

    3.21.2) SUMMARY/HUMAN
    A) Persons chronically exposed to paint may be at increased risk for bladder tumors, laryngeal or esophageal cancer, lung cancer, cancers of the bowel/rectum and intrahepatic bile ducts, and leukemia and multiple myeloma.
    3.21.3) HUMAN STUDIES
    A) CARCINOMA
    1) Chronic paint exposure has been associated with an increased risk of developing BLADDER (Myslak et al, 1991; Silverman et al, 1989; Matanoski et al, 1986), LARYNX (Englund, 1980; Brown et al, 1988), ESOPHAGUS (Englund, 1980), LUNG (Stockwell & Matanoski, 1985; Matanoski et al, 1986), BILE DUCT (Englund, 1980), and BOWEL AND RECTUM (Morgan et al, 1981) cancer, LEUKEMIA (Sandler, 1987; Matanoski et al, 1986), and MULTIPLE MYELOMA (Lundberg, 1986).
    2) Scandinavian painters were at increased risk for developing cancers of the lung, oral cavity, esophagus, and liver, even after such confounders as cigarette smoking and ethanol drinking were considered (Skov et al, 1993). Persons chronically exposed to paint may be at increased risk for
    B) BLADDER CARCINOMA
    1) Persons with past employment as painters had a 2.76-fold increased risk for bladder tumors when compared with a control group of persons with prostate disease (Myslak et al, 1991).
    2) Painters were 1 of the occupational groups most at risk for bladder cancer in the National Bladder Cancer Study; the overall relative risk was 1.5 and ranged as high as 3.0 for older and longer exposures (Silverman et al, 1989).
    3) US painters from 4 states were at increased risk for mortality from cancer of the bladder (Matanoski et al, 1986).
    C) LARYNX CARCINOMA
    1) Workers potentially exposed to paint had elevated risk of laryngeal cancer (Englund, 1980; Brown et al, 1988). Esophageal cancers were also elevated (Englund, 1980).
    D) LEUKEMIA
    1) Chronic exposure to paint has been associated with increased risk for acute myelogenous leukemia (Sandler, 1987). US painters from 4 states were at increased risk of mortality from leukemia, after correction for nonoccupational factors (Matanoski et al, 1986). Children of fathers who were exposed to spray paint during pregnancy or after birth were at 2-fold increased risk for leukemia (Lowengart et al, 1987).
    2) Painting was identified as a risk factor for development of leukemias (acute myeloid, acute lymphocytic, various preleukemic states) in a large case-control study on Italian patients (Mele et al, 1994).
    E) PULMONARY CARCINOMA
    1) Painters who never wore a mask or respirator were at 5-fold excess risk for lung cancer when compared with random controls from a trade union population (Stockwell & Matanoski, 1985). An increased risk of mortality from lung cancer was still evident after correction for nonoccupational factors (Matanoski et al, 1986). Another study also found that painters had an increased risk of mortality from lung cancer (Skov et al, 1993).
    F) HEPATIC CARCINOMA
    1) Painters showed an excess of cancer of the intrahepatic bile ducts (Englund, 1980).
    G) MYELOMATOSIS MULTIPLE
    1) A group of Swedish workers in the paint manufacturing industry had a 5-fold greater than expected risk of mortality from multiple myeloma (Lundberg, 1986).
    H) GASTRIC CARCINOMA
    1) Increased mortality from bowel and rectal cancer was seen in a group of 16,243 men employed in the manufacture of paint and varnish; there was no major health hazard overall in this group, however (Morgan et al, 1981).
    I) MOUTH CARCINOMA
    1) An increased risk of mortality from pharyngeal cancer was found in painters from Norway, Finland, and Denmark, and an increased risk of death from cancer of the mouth was found in painters from Sweden in 1 study involving painters from all Nordic countries (Skov et al, 1993).

Genotoxicity

    A) Increased numbers of sister chromatid exchanges were seen in smokers recently exposed to paint solvents.

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) No specific lab work is needed after exposure to most paints.
    B) Obtain a serum lead concentration after acute ingestion or chronic exposure to lead based paint.
    C) Obtain urinary (mercury, manganese, cobalt), blood (cadmium, manganese) concentrations of specific heavy metals after significant exposure to paints that contain them.
    D) Obtain serum electrolytes after deliberate or prolonged inhalation of paint containing toluene or ingestion of paint containing barium.
    E) Obtain CBC, renal function, and hepatic enzymes in symptomatic patients.
    F) Chest radiographs as needed clinically for suspected aspiration.
    G) An abdominal radiograph may be useful to assess the adequacy of decontamination after ingestion of paint containing lead or other heavy metals.
    4.1.2) SERUM/BLOOD
    A) BLOOD/SERUM CHEMISTRY
    1) Alcohol levels may be appropriate when indicated.
    2) Levels of serum isocyanate-specific IgG have correlated better with exposure to isocyanates than with development of symptoms (Selden et al, 1989).
    3) A specific heavy metal blood level (ie, blood lead) may be helpful, as may a chest X-ray for aspiration hazard. Obtain CBC, renal, and hepatic function studies as indicated. Individual hydrocarbon blood levels have only medicolegal value.
    4.1.3) URINE
    A) URINARY LEVELS
    1) Monitor urinary excretion of heavy metals as indicated. Refer to documents on the specific metal involved for more information.
    4.1.4) OTHER
    A) OTHER
    1) PULMONARY FUNCTION TESTS
    a) Persons chronically exposed to paints containing isocyanates, amines, phthalic acid anhydride, trimellitic acid, or formaldehyde should be periodically evaluated with pulmonary function testing (Kilburn, 1982).
    2) MONITORING
    a) A specific heavy metal blood level (ie, blood lead) may be helpful, as may a chest X-ray for aspiration hazard and CBC, renal, and hepatic function studies as indicated. Individual hydrocarbon blood levels have only medicolegal value.

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Patients with persistent symptoms of aspiration or with acute symptoms of heavy metal poisoning should be admitted.
    6.3.1.2) HOME CRITERIA/ORAL
    A) Patients with symptoms limited to minor irritation after inadvertent exposure to paints that do not contain heavy metals can be managed at home.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Consult a medical toxicologist or poison center for patients with significant ingestions of paints containing heavy metals. Refer patients who recreationally inhale solvent based paints for substance abuse counseling. Consult a pulmonologist for patients with severe aspiration.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Patients with clinical evidence of aspiration (cough, increased work of breathing, wheezing) or ingestion of paints that contain heavy metals should be referred to a healthcare facility. Patients who deliberately inhale solvent based paint should be referred to a healthcare facility.

Monitoring

    A) No specific lab work is needed after exposure to most paints.
    B) Obtain a serum lead concentration after acute ingestion or chronic exposure to lead based paint.
    C) Obtain urinary (mercury, manganese, cobalt), blood (cadmium, manganese) concentrations of specific heavy metals after significant exposure to paints that contain them.
    D) Obtain serum electrolytes after deliberate or prolonged inhalation of paint containing toluene or ingestion of paint containing barium.
    E) Obtain CBC, renal function, and hepatic enzymes in symptomatic patients.
    F) Chest radiographs as needed clinically for suspected aspiration.
    G) An abdominal radiograph may be useful to assess the adequacy of decontamination after ingestion of paint containing lead or other heavy metals.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) Wash exposed skin with soap and water; mineral oil may help remove oil based paint. Irrigate exposed eyes.
    B) GI decontamination is generally not indicated because of the low risk of acute toxicity and the possibility of aspiration. Activated charcoal can be considered after ingestion of lead based paint.
    C) ACTIVATED CHARCOAL
    1) PREHOSPITAL ACTIVATED CHARCOAL ADMINISTRATION
    a) Consider prehospital administration of activated charcoal as an aqueous slurry in patients with a potentially toxic ingestion who are awake and able to protect their airway. Activated charcoal is most effective when administered within one hour of ingestion. Administration in the prehospital setting has the potential to significantly decrease the time from toxin ingestion to activated charcoal administration, although it has not been shown to affect outcome (Alaspaa et al, 2005; Thakore & Murphy, 2002; Spiller & Rogers, 2002).
    1) In patients who are at risk for the abrupt onset of seizures or mental status depression, activated charcoal should not be administered in the prehospital setting, due to the risk of aspiration in the event of spontaneous emesis.
    2) The addition of flavoring agents (cola drinks, chocolate milk, cherry syrup) to activated charcoal improves the palatability for children and may facilitate successful administration (Guenther Skokan et al, 2001; Dagnone et al, 2002).
    2) CHARCOAL DOSE
    a) Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005).
    1) Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
    b) ADVERSE EFFECTS/CONTRAINDICATIONS
    1) Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information.
    2) Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
    6.5.2) PREVENTION OF ABSORPTION
    A) SUMMARY
    1) GI decontamination is generally not indicated because of the low risk of acute toxicity and the possibility of aspiration. Activated charcoal and/or gastric lavage can be considered after substantial ingestion of lead based paint. Wash exposed skin with soap and water; mineral oil may help remove oil based paint. Irrigate exposed eyes.
    B) GASTRIC LAVAGE
    1) INDICATIONS: Consider gastric lavage with a large-bore orogastric tube (ADULT: 36 to 40 French or 30 English gauge tube {external diameter 12 to 13.3 mm}; CHILD: 24 to 28 French {diameter 7.8 to 9.3 mm}) after a potentially life threatening ingestion if it can be performed soon after ingestion (generally within 60 minutes).
    a) Consider lavage more than 60 minutes after ingestion of sustained-release formulations and substances known to form bezoars or concretions.
    2) PRECAUTIONS:
    a) SEIZURE CONTROL: Is mandatory prior to gastric lavage.
    b) AIRWAY PROTECTION: Place patients in the head down left lateral decubitus position, with suction available. Patients with depressed mental status should be intubated with a cuffed endotracheal tube prior to lavage.
    3) LAVAGE FLUID:
    a) Use small aliquots of liquid. Lavage with 200 to 300 milliliters warm tap water (preferably 38 degrees Celsius) or saline per wash (in older children or adults) and 10 milliliters/kilogram body weight of normal saline in young children(Vale et al, 2004) and repeat until lavage return is clear.
    b) The volume of lavage return should approximate amount of fluid given to avoid fluid-electrolyte imbalance.
    c) CAUTION: Water should be avoided in young children because of the risk of electrolyte imbalance and water intoxication. Warm fluids avoid the risk of hypothermia in very young children and the elderly.
    4) COMPLICATIONS:
    a) Complications of gastric lavage have included: aspiration pneumonia, hypoxia, hypercapnia, mechanical injury to the throat, esophagus, or stomach, fluid and electrolyte imbalance (Vale, 1997). Combative patients may be at greater risk for complications (Caravati et al, 2001).
    b) Gastric lavage can cause significant morbidity; it should NOT be performed routinely in all poisoned patients (Vale, 1997).
    5) CONTRAINDICATIONS:
    a) Loss of airway protective reflexes or decreased level of consciousness if patient is not intubated, following ingestion of corrosive substances, hydrocarbons (high aspiration potential), patients at risk of hemorrhage or gastrointestinal perforation, or trivial or non-toxic ingestion.
    C) ACTIVATED CHARCOAL
    1) CHARCOAL ADMINISTRATION
    a) Consider administration of activated charcoal after a potentially toxic ingestion (Chyka et al, 2005). Administer charcoal as an aqueous slurry; most effective when administered within one hour of ingestion.
    2) CHARCOAL DOSE
    a) Use a minimum of 240 milliliters of water per 30 grams charcoal (FDA, 1985). Optimum dose not established; usual dose is 25 to 100 grams in adults and adolescents; 25 to 50 grams in children aged 1 to 12 years (or 0.5 to 1 gram/kilogram body weight) ; and 0.5 to 1 gram/kilogram in infants up to 1 year old (Chyka et al, 2005).
    1) Routine use of a cathartic with activated charcoal is NOT recommended as there is no evidence that cathartics reduce drug absorption and cathartics are known to cause adverse effects such as nausea, vomiting, abdominal cramps, electrolyte imbalances and occasionally hypotension (None Listed, 2004).
    b) ADVERSE EFFECTS/CONTRAINDICATIONS
    1) Complications: emesis, aspiration (Chyka et al, 2005). Aspiration may be complicated by acute respiratory failure, ARDS, bronchiolitis obliterans or chronic lung disease (Golej et al, 2001; Graff et al, 2002; Pollack et al, 1981; Harris & Filandrinos, 1993; Elliot et al, 1989; Rau et al, 1988; Golej et al, 2001; Graff et al, 2002). Refer to the ACTIVATED CHARCOAL/TREATMENT management for further information.
    2) Contraindications: unprotected airway (increases risk/severity of aspiration) , nonfunctioning gastrointestinal tract, uncontrolled vomiting, and ingestion of most hydrocarbons (Chyka et al, 2005).
    6.5.3) TREATMENT
    A) SUPPORT
    1) MANAGEMENT OF MILD TO MODERATE TOXICITY: Treatment is symptomatic and supportive.
    2) MANAGEMENT OF SEVERE TOXICITY: Chelation may be necessary for patients with significant exposure to paints containing heavy metals. OBSERVE FOR ASPIRATION PNEUMONITIS and treat accordingly (see hydrocarbon management). Suspect aspiration if coughing or choking occurs following ingestion of oil-based paints. Aspiration pneumonitis should be treated with oxygen, inhaled beta agonists for bronchospasm, and in severe cases endotracheal intubation may be necessary.
    B) MONITORING OF PATIENT
    1) No specific lab work is needed after exposure to most paints.
    2) Obtain a serum lead concentration after acute ingestion or chronic exposure to lead based paint.
    3) Obtain urinary (mercury, manganese, cobalt), blood (cadmium, manganese) concentrations of specific heavy metals after significant exposure to paints that contain them.
    4) Obtain serum electrolytes after deliberate or prolonged inhalation of paint containing toluene or ingestion of paint containing barium.
    5) Obtain CBC, renal function, and hepatic enzymes in symptomatic patients.
    6) Chest radiographs as needed clinically for suspected aspiration.
    7) An abdominal radiograph may be useful to assess the adequacy of decontamination after ingestion of paint containing lead or other heavy metals.
    C) CHELATION THERAPY
    1) Chelation should be initiated for heavy metal poisoning as indicated. See specific heavy metal managements.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    B) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    C) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) Materials in paints may be eye irritants.
    B) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) Patients exposed dermally should wash the exposed area twice with soap and water. Oil-based paint may be removed from the skin with mineral oil (baby oil). A physician may need to examine the exposed area if irritation or pain persists after the area is washed.
    2) Dried paint will eventually wear off when the top layer of old skin sheds.

Case Reports

    A) ACUTE EFFECTS
    1) A 43-year-old male patient developed fatal meningoencephalitis with eosinophilia following sealing a floor with lacquer (Kleinert et al, 1986).
    2) A 60-year-old man developed an acute confusional state lasting 3 days, following heavy exposure to the fumes of a polyurethane gloss paint. Transient bone marrow suppression and liver cell damage were seen after recovery from the acute neurological effects (Atkinson et al, 1989).
    B) ADVERSE EFFECTS
    1) A 39-year-old shipwright developed delayed pruritus, erythema, and vesiculation on the wrists and forearms after using an antifouling paint containing tributyl tin oxide (Lewis & Emmett, 1987).
    2) A 25-year-old male developed allergic contact dermatitis on the forehead, ears, perioral skin, and upper cheeks after spraying a triglycidyl-isocyanurate-based powdered paint (Mathias, 1988).
    3) A person staying in a summer cottage developed acute facial dermatitis, which was traced to the chlorothalonil pesticide used in the interior paint (Liden, 1990).

Summary

    A) TOXICITY: A toxic dose is not known because of the variety and concentrations of ingredients in paints. A dose of concern is about 5 mL/kg.
    B) Symptomatic heavy metal toxicity (eg, arsenic, mercury) is unlikely following ingestion, unless massive amounts have been ingested or smaller amounts have been ingested or inhaled over a long period of time. Elevated blood lead concentrations can develop after acute ingestion of lead based paints.

Toxicologic Mechanism

    A) SOLVENT
    1) See individual compounds such as hydrocarbon or petroleum distillate, oil, resin, filler, and pigment.
    2) The typical paint mixture contains a low percentage (5% to 25%) of pigment and a high percentage (75% to 90%) of solvent (hydrocarbon or water), filler, and resin.
    3) Hydrocarbons such as mineral spirits (naphtha), aromatic hydrocarbons (toluene, xylene), and other petroleum distillates may be the vehicle in paint. Linseed oil is also commonly used as a vehicle and may cause diarrhea.
    4) Varnishes and shellacs contain other organic solvents such as alcohol (ethyl or, rarely, methyl), ketones, and esters.
    5) Water is usually the solvent in latex-type paint.
    6) Aerosol paints contain the usual compounds in addition to a propellant, usually of the freon or propane type or a combination.
    B) PIGMENTS
    1) There are more than 200 pigment compounds; only a few are potentially toxic in the volume and concentration of the average ingestion.
    2) Pigments include the salts of iron, antimony, copper, manganese, barium, nickel, cobalt, zinc, aluminum and strontium as well as gold, silver, tin chromates, cadmium, arsenic, lead, aniline, and ferrocyanides. Cupric aceto-arsenite, known as Paris Green, is probably the most toxic pigment.
    3) Cadmium-containing pigments are also toxic. Iron oxide (ferric oxide) is not considered toxic by ingestion.
    4) Toluidine red (Hansa red, pigment red 3) may cause cyanosis due to methemoglobinemia when ingested by children (McCann, 1979). Deeper color paints contain more color pigment.
    5) Inert filler pigments are of low-order toxicity and include asbestine (talc), calcium carbonate (whiting), calcium sulfate, china clay (aluminum silicate), silica and silicates, and magnesium silicate (talc) (Gosselin, 1984).
    6) CI reactive dyes (Procion(R) dyes) may produce allergic hypersensitivity reactions (Alanko et al, 1978; Hagmar et al, 1986; Estlander, 1988).
    C) FUNGICIDES/PRESERVATIVES
    1) Exterior latex paints may contain mercury fungicides. "Mildew-Resistant" house paints usually have mercury compounds (phenylmercury oleate, phenylmercury acetate, or phenylmercury succinate). If there is less than 0.2% mercury compound, the special warning label is not required (Gosselin, 1984).
    a) The use of mercury-based biocides in INTERIOR paints was canceled by the US EPA, effective August 20, 1990. Existing stocks of pesticides were allowed to be sold and used for manufacture of exterior products until June 27, 1991, provided they are properly labeled with language prohibiting use in interior paints and coatings (EPA, 1990).
    b) Because current inventories were not affected, paints containing mercury-based biocides may still be available on the market.
    2) Some stain products may contain wood preservatives, such as pentachlorophenol, in the range of 3% to 5%, and should be listed on the label (Gosselin, 1984).
    D) LEAD
    1) "Fume-Proof" or "Fume-Resistant" house paints denote NO lead content. White lead may be found in white and colored house paints (basic carbonate white lead, basic sulfate white lead, basic silicate white lead, leaded zinc oxide, and lead titanate) and requires a lead warning statement on the label (Gosselin, 1984).

General Bibliography

    1) Agocs MM, Etzel RA, & Parrish RG: Mercury exposure from interior latex paint. N Engl J Med 1990; 323:1096-1101.
    2) Alanko K, Keskinen H, & Bjorksten F: Immediate-type hypersensitivity to reactive dyes. Clin Allergy 1978; 8:25-31.
    3) Alaspaa AO, Kuisma MJ, Hoppu K, et al: Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 45:207-12.
    4) Andersen KE & Petri M: Occupational irritant contact folliculitis associated with triphenyl tin fluoride (TPTF) exposure. Contact Dermatitis 1982; 8:173-177.
    5) Anon: Colorado Disease Bulletin, Vol XV, Issue 9 (May 1). CDPHE, 1987.
    6) Atkinson L, Ince P, & Smith NM: Toxic reaction to inhaled paint fumes. Postgrad Med J 1989; 65:559-562.
    7) Belin L, Hjortsberg U, & Wass U: Life-threatening pulmonary reaction to car paint containing a prepolymerized isocyanate (Letter). Scand J Work Environ Health 1981; 7:310-311.
    8) Bolla KI, Schwartz BS, & Agnew J: Subclinical neuropsychiatric effects of chronic low-level solvent exposure in US paint manufacturers. J Occup Med 1990; 32:671-677.
    9) Brown LM, Mason TJ, & Pickle LW: Occupational risk factors for laryngeal cancer on the Texas Gulf Coast. Cancer Res 1988; 48:1960-1964.
    10) Bruhn P, Arlien-Sborg P, & Gyldensted C: Prognosis in chronic toxic encephalopathy. A two-year follow-up study in 26 house painters with occupational encephalopathy. ACTA Neurol Scand 1981; 64:259-272.
    11) CDC: Mercury exposure from interior latex paint -- Michigan. CDC: MMWR 1990; 39:125-126.
    12) Caravati EM, Knight HH, & Linscott MS: Esophageal laceration and charcoal mediastinum complicating gastric lavage. J Emerg Med 2001; 20:273-276.
    13) Carmichael AJ & Foulds IS: Allergic contact dermatitis due to an amino-substituted diacrylate in a UV-cured lacquer. Contact Dermatitis 1993; 28:45-46.
    14) Cartier A, Vandenplas O, & Grammer LC: Respiratory and systemic reaction folowing exposure to heated electrostatic polyester paint. Eur Respir J 1994; 7:608-611.
    15) Chang S: Update: Mercury in latex paints. Art Hazard News 1990; 13:2.
    16) Chen J-D, Wang J-D, & Jang J-P: Exposure to mixtures of solvents among paint workers and biochemical alterations of liver function. Br J Ind Med 1991; 48:696-701.
    17) Chen R, Wei L, & Seaton A: Neuropsychological symtpoms in Chinese male and female painters: an epidemiological study in dockyard workers. Occup Environ Med 1999; 56:388-390.
    18) Chyka PA, Seger D, Krenzelok EP, et al: Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 2005; 43(2):61-87.
    19) Colvin M, Myers J, & Nell V: A cross-sectional survey of neurobehavioral effects of chronic solvent exposure on workers in a paint manufacturing plant. Environ Res 1993; 63:122-132.
    20) Dagnone D, Matsui D, & Rieder MJ: Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers. Pediatr Emerg Care 2002; 18:19-21.
    21) Daniell W, Stebbins A, & O'Donnell J: Neuropsychological performance and solvent exposure among car body repair shop workers. Br J Ind Med 1993; 50:368-377.
    22) Demers RY, Markell BL, & Wabeke R: J Occup Med 1991; 33:1051-1054.
    23) Dossing M, Arlien-Soborg P, & Petersen L: Liver damage associated with occupational exposure to organic solvents in house painters. Eur J Clin Invest 1983; 13:151-157.
    24) EPA: Federal Register: 55 FR 26754, Government Printing Office, Washington, DC, 1990.
    25) Elliot CG, Colby TV, & Kelly TM: Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674.
    26) Englund A: Cancer incidence among painters and some allied trades. J Toxicol Environ Health 1980; 6:1267-1273.
    27) Errebo-Knudsen EO & Olsen F: Organic solvents and presenile dementia (the painter's syndrome). A critical review of the Danish literature. Sci Total Environ 1986; 48:45-67.
    28) Estlander T: Allergic dermatoses and respiratory diseases from reactive dyes. Contact Dermatits 1988; 18:290-297.
    29) FDA: Poison treatment drug product for over-the-counter human use; tentative final monograph. FDA: Fed Register 1985; 50:2244-2262.
    30) Fidler AT: Br J Ind Med 1987; 44:292-308.
    31) Finkbeiner H & Kleinhans D: Airborne allergic contact dermatitis caused by preservatives in home-decorating paints. Contact Dermatits 1994; 31:275-276.
    32) Fischer T, Bohlin S, & Edling C: Skin disease and contact sensitivity in house painters using water-based paints, glues and putties. Contact Dermatitis 1995; 32:39-43.
    33) Foulds IS & Koh D: Allergic contact dermatitis from resin hardeners during the manufacture of thermosetting coating paints. Contact Dermatitis 1992; 26:87-90.
    34) Fuchs J, Hengstler JG, & Hummrich F: Transient increase in DNA strand breaks in car refinishing spray painter. Scand J Work Environ Health 1996; 22:438-443.
    35) Goh CL: Irritant contact dermatitis from tri-N-butyl tin oxide in paint. Contact Dermatitis 1985; 12:161-163.
    36) Golej J, Boigner H, Burda G, et al: Severe respiratory failure following charcoal application in a toddler. Resuscitation 2001; 49:315-318.
    37) Goodwin TM: Toluene abuse and renal tubular acidosis in pregnancy. Obstet Gynecol 1988; 71:715-718.
    38) Gosselin R: Clinical Toxicology of Commercial Products, 5th ed, 1, Williams & Wilkins, Baltimore, MD, 1984, pp 82-84-164-195.
    39) Graff GR, Stark J, & Berkenbosch JW: Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961.
    40) Grasso P, Sharratt M, & Davies DM: Neurophysiological and psychological disorders and occupational exposure to organic solvents. Food Chem Toxicol 1984; 22:819-852.
    41) Gregory AR: The carcinogenic potential of benzidine-based dyes. J Environ Pathol Toxicol Oncol 1984; 5:243-259.
    42) Greig DE: Another isothiazolinone source. Contact Dermatitis 1991; 25:201-202.
    43) Grosch JW, Neale AV, & Demers RY: Neurobehavioral and health-related deficits in solvent-exposed painters. Am J Ind Med 1996; 30:623-632.
    44) Guenther Skokan E, Junkins EP, & Corneli HM: Taste test: children rate flavoring agents used with activated charcoal. Arch Pediatr Adolesc Med 2001; 155:683-686.
    45) Guiguet M, Baumelou E, & Mary JY: A case-control study of aplastic anaemia -- occupational exposures. Internat J Epidemiol 1995; 24:993-999.
    46) Haglund U: Scand J Work Environ Health 1980; 6:291-298.
    47) Hagmar L, Welinder H, & Dahlquist I: Immunoglobulin E antibodies against a reactive dye -- a case report. Scand J Work Environ Health 1986; 12:221-222.
    48) Hansen MK, Larsen M, & Cohr KH: Waterborne paints. A review of their chemistry and toxicology and the results of determinations made during their use. Scand J Work Environ Health 1987; 13:473-485.
    49) Harris CR & Filandrinos D: Accidental administration of activated charcoal into the lung: aspiration by proxy. Ann Emerg Med 1993; 22:1470-1473.
    50) Harter BT Jr & Harter KC: High-pressure injection injuries. Hand Clin 1986; 2:547-552.
    51) Heidam LZ: J Epidemiol Community Health 1984; 38:149-155.
    52) Herrick RT, Godsil RD, & Widener JH: High-pressure injection injuries to the hand. South Med J 1980; 73:896-898.
    53) Holmberg PC & Nurminen M: Am J Ind Med 1980; 1:167-176.
    54) Holmberg PC: Lancet 1979; 2:177-179.
    55) ILO: Encyclopaedia of Occupational Health and Safety, 3rd ed. Vols 1-2, International Labour Organization, Geneva, Switzerland, 1983.
    56) Jolanki R, Kanerva L, & Estlander T: Occupational allergic contact dermatatis caused by epoxy diacrylate in ultraviolet-light-cured paint, and bisphenol A in dental composite resin. Contact Dermatitis 1995; 33:94-99.
    57) Joly M, Ballet Y, & Boudene C: Les derives du plomb dans la peinture et la diversite de leurs impacts toxicologiques (French). J Toxicol Clin Exp 1987; 7:309-322.
    58) Kalman D: Toxicol Lett 1984; 22:301-306.
    59) Kanerva L, Keskinen H, & Autio P: Occupational respiratory and skin sensitization caused by polyfunctional aziridine hardener. Clin Exp Allergy 1995; 25:432-439.
    60) Kaufman HD: The clinicopathological correlation of high-pressure injection injuries. Br J Surg 1968; 55:214-218.
    61) Kelsey KT, Wiencke JK, & Little FF: Sister chromatid exchange in painters recently exposed to solvents. Environ Res 1989; 50:248-255.
    62) Kilburn KH: Respiratory symptoms due to paint exposure. Adv Mod Environ Toxicol 1982; 2:153-156.
    63) Kleinert R, Kleinert G, & Walter GF: Fatal eosinophilic meningoencephalitis following lacquer poisoning. Case report and differential diagnostic considerations. Eur Arch Psychiatry Neurol Sci 1986; 235:378-388.
    64) Kullavanijaya P & Ophaswongse S: A study of dermatitis in the lacquerware industry. Contact Derm 1997; 36:244-246.
    65) Lewis PG & Emmett EA: Irritant dermatitis from tri-butyl tin oxide and contact allergy from chlorocresol. Contact Dermatitis 1987; 17:129-132.
    66) Liden C: Facial dermatitis caused by chlorothalonil in a paint. Contact Dermatitis 1990; 22:206-211.
    67) Linz DH, de Garmo PL, & Morton WE: Organic solvent-induced encephalopathy in industrial painters. J Occup Med 1986; 28:119-125.
    68) Liu JJY, Bai CL, & Williamson AM: Individual serum bile acids in apprentice spray painters in association with solvent exposure. Int Arch Occup Environ Health 1996; 69:21-26.
    69) Lowengart RA, Peters JM, & Cicioni C: Childhood leukemia and parents' occupational and home exposures. J Natl Cancer Inst 1987; 79:39-46.
    70) Lundberg I & Hakansson M: Br J Ind Med 1985; 42:596-600.
    71) Lundberg I, Michelsen H, & Nise G: Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents. Scand J Work Environ Health 1995; 21 (suppl 1):1.
    72) Lundberg I: Mortality and cancer incidence among Swedish paint industry workers with long-term exposure to organic solvents. Scand J Work Environ Health 1986; 12:108-113.
    73) MacLean AL: A common epithelial keratitis from noncorrosive household sprays. Trans Am Acad Ophthalmol Otolaryngol 1967; 71:330-340.
    74) Matanoski GM, Stockwell HG, & Diamond EL: A cohort mortality study of painters and allied tradesmen. Scand J Work Environ Health 1986; 12:16-21.
    75) Mathias CGT: Allergic contact dermatitis from triglycidyl isocyanurate in polyester paint pigments. Contact Dermatitis 1988; 19:67-68.
    76) McCann M: Artists Beware, Watson-Guptill Publications, New York, NY, 1979, pp 147.
    77) McFadden JP & Rycroft RJG: Occupational contact dermatitis from triglycidyl isocyanurate in a powder paint sprayer. Contact Dermatitis 1993; 28:251.
    78) Mele A, Szklo M, & Visani G: Hair dye use and other risk factors for leukemia and pre-leukemia -- a case-control study. Am J Epidemiol 1994; 139:609-619.
    79) Mergler D & Blain L: Assessing color vision loss among solvent-exposed workers. Am J Ind Med 1987; 12:195-203.
    80) Morgan RW, Kaplan SD, & Gaffey WR: A general mortality study of production workers in the paint and coatings manufacturing industry. A preliminary report. J Occup Med 1981; 23:13-21.
    81) Moura C, Dias M, & Vale T: Contact dermatitis in painters, polishers and varnishers. Contact Dermatitis 1994; 31:51-53.
    82) Moya C, Anto JM, & Newman Taylor AJ: Outbreak of organising pneumonia in textile printing sprayers. Lancet 1994; 344:498-502.
    83) Mrvos R, Dean BS, & Krenzelok EP: High pressure injection injuries: a serious occupational hazard. J Toxicol Clin Toxicol 1987; 25:297-304.
    84) Myslak ZW, Bolt HM, & Brockmann W: Tumors of the urinary bladder in painters: a case-control study. Am J Ind Med 1991; 19:705-713.
    85) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    86) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    87) Neal NC & Burke FD: High-pressure injection injuries. Injury 1991; 22:467-470.
    88) Nielsen J, Sango C, & Winroth G: Systemic reactions associated with polyisocyanate exposure. Scand J Work Environ Health 1985; 11:51-54.
    89) None Listed: Position paper: cathartics. J Toxicol Clin Toxicol 2004; 42(3):243-253.
    90) Omer SA & Al-Tawil NG: Contact sensitivity among workers in a paint factory. Contact Dermatitis 1994; 30:55-57.
    91) Parker DL, Waller K, & Himrich B: A cross-sectional study of pulmonary function in autobody repair workers. Am J Public Health 1991; 81:768-771.
    92) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    93) Pisaniello DL & Muriale L: The use of isocyanate paints in auto refinishing. A survey of isocynanate exposures and related work practices in South Australia. Ann Occup Hyg 1989; 33:563-572.
    94) Pollack MM, Dunbar BS, & Holbrook PR: Aspiration of activated charcoal and gastric contents. Ann Emerg Med 1981; 10:528-529.
    95) Rabinowitz M, Leviton A, & Bellinger D: Home refinishing, lead paint, and infant blood lead levels. Am J Public Health 1985; 75:403-404.
    96) Rau NR, Nagaraj MV, Prakash PS, et al: Fatal pulmonary aspiration of oral activated charcoal. Br Med J 1988; 297:918-919.
    97) Reisch MS: Higher paint sales brighten profits outlook. C&E News 1991; 69:29-32,34-36,38,42,45,47,49-52,55,58.
    98) Reisch MS: Marine paint strives to meet environmental concerns. C&E News 1990; 68:39-40,41,43,49-54,56,58,61-62,64,68.
    99) Rempel D, Jones J, & Atterbury M: Respiratory effects of exposure of shipyard workers to epoxy paints. Br J Ind Med 1991; 48:783-787.
    100) Rosenberg C & Tuomi T: Airborne isocyanates in polyurethane spray painting: determination and respirator efficiency. Am Ind Hyg Assoc J 1984; 45:117-121.
    101) Sandler DP: Epidemiology of acute myelogenous leukemia. Semin Oncol 1987; 14:359-364.
    102) Sanz-Gallen P, Planas J, & Martinez P: Allergic contact dermatitis due to 1,2-benzisothiazolin-3-one in paint manufacture. Contact Dermatitis 1992; 27:271-272.
    103) Sardas S, Karakaya AE, & Furtun Y: Sister chromatid exchanges in workers employed in car-painting workshops. Internat Arch Occup Environ Health 1994; 66:33-35.
    104) Schoo MJ, Scott Fa, & Boswick JA: High-pressure injection injuries of the hand. J Trauma 1980; 20:229-238.
    105) Schwartz DA & Baker EL: Respiratory illness in the construction industry. Airflow obstruction among painters. Chest 1988; 93:134-137.
    106) Scott AR: Occupational high-pressure injection injuries: pathogenesis and prevention. J Soc Occup Med 1983; 33:56-59.
    107) Selden AI, Belin L, & Wass U: Isocyanate exposure and hypersensitivity pneumonitis -- report of a probable case and prevalence of specific immunoglobulin G antibodies among exposed individuals. Scand J Work Environ Health 1989; 15:234-237.
    108) Shibata K, Yoshita Y, & Matsumoto H: Extensive chemical burns from toluene. Am J Emerg Med 1994; 12:353-355.
    109) Silva JM & Santos-Mello R: Chromosomal aberrations in lymphocytes from car painters. Mutat Res 1996; 368:21-25.
    110) Silverman DT, Levin LI, & Hoover RN: Occupational risks of bladder cancer in the United States. I. White men. J Natl Cancer Inst 1989; 81:1472-1480.
    111) Sjogren B, Backstrom I, & Fryk G: Fever and respiratory symptoms after welding on painted steel. Scand J Work Environ Health 1991; 17:441-443.
    112) Sole A, Cordero PJ, & Morales P: Epidemic outbreak of interstitial lung disease in aerographics textile workers - the "Ardystil syndrome": a first year follow up. Thorax 1996; 51:94-95.
    113) Spiller HA & Rogers GC: Evaluation of administration of activated charcoal in the home. Pediatrics 2002; 108:E100.
    114) Spurgeon A, Gray CN, & Sims J: Neurobehavioral effects of long-term occupational exposure to organic solvents: two comparable studies. Am J Ind Med 1992; 22:325-335.
    115) Stern MA: Occupational asthma from a reactive dye. Ann Allergy 1985; 55:264.
    116) Stewart L & Beck MH: Contact sensitivity to methyl ethyl ketone peroxide in a paint sprayer. Contact Dermatitis 1992; 26:52-53.
    117) Stockwell HG & Matanoski GM: A case-control study of lung cancer in painters. J Occup Med 1985; 27:125-126.
    118) Tamakawa K: Dandai-Shi Eisei Shikenshoho 1983; 13:246-257.
    119) Tangredi G, Carbone U, & Rossi L: Environmental conditions in a paint factory and effects on employee health (Italian). Med Lav 1981; 5:325-337.
    120) Thacker JG, Edlich RF, & Rodeheaver GT: High-pressure injection injuries, in: Edlich RF & Spyker DA (Eds). Current Emergency Therapy, 3rd ed, Aspen Publications, Rockville, MD, 1986, pp 269-273.
    121) Thakore S & Murphy N: The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63-65.
    122) Thoren K, Meding B, & Nordlinger R: Contact dermatitis and asthma from reactive dyes. Contact Dermatitis 1986; 15:186-193.
    123) Tornling G, Alexandersson R, & Hedenstierna G: Decreased lung function and exposure to diisocyanates (HDI and HDI-BT) in car repair painters: observations on re-examination 6 years after initial study. Am J Ind Med 1990; 17:299-310.
    124) Ulfvarson U, Alexandersson R, & Dahlqvist M: Temporary health effects from exposure to water-borne paints. Scand J Work Environ Health 1992; 18:376-387.
    125) Vale JA, Kulig K, American Academy of Clinical Toxicology, et al: Position paper: Gastric lavage. J Toxicol Clin Toxicol 2004; 42:933-943.
    126) Vale JA: Position Statement: gastric lavage. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997; 35:711-719.
    127) Wax PM & Dockstader L: Tributyltin use in interior paints: a continuing health hazard. Clin Toxicol 1995; 33:239-241.
    128) Welch LS, Plotkin E, & Schrader S: Indirect fertility analysis in painters exposed to ethylene glycol ethers: sensitivity and specificity. Am J Ind Med 1991; 20:229-240.
    129) Wieslander G, Norback D, & Edling C: Occupational exposure to water based paint and symptoms from the skin and eyes. Occup Environ Med 1994; 51:181-186.